Insulin, human recombinant, zinc solution and 2 more items

Life Technologies Corporation has been awarded contract A207_PO-0446865 by the University of Virginia on June 9, 2026, for the procurement of laboratory and biotechnology supplies valued at $280. The contract encompasses three distinct line items totaling five units, all to be delivered to Guyzuin Hu at the University of Virginia in Virginia. The procurement includes insulin human recombinant zinc solution (two units at $61 per unit), McCoy's 5A Modified Medium in 500 milliliter quantities (two units at $22.08 per unit), and human epidermal growth factor recombinant protein (one unit at $114).

These supplies are consistent with research and development activities in biotechnology and cellular biology. The University of Virginia, serving as the contracting organization, procured these materials through Life Technologies Corporation, a qualified supplier of specialized laboratory reagents and biological products. The contract represents a routine procurement transaction for research consumables with no specified contract period of performance identified in the award documentation.